Hepatitis C virus drives the unconstrained monoclonal expansion of V H1-69-expressing memory B cells in type II cryoglobulinemia: A model of infection-driven lymphomagenesis

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6532-6539

  Carbonari, Maurizio ^a   Caprini, Elisabetta ^b   Tedesco, Tiziana ^a   Mazzetta, Francesca ^a   Tocco, Valeria ^b   Casato, Milvia ^a   Russo, Giandomenico ^b   Fiorilli, Massimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; FAS ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL SIZE; CLINICAL ARTICLE; CLONAL VARIATION; CRYOGLOBULINEMIA; DOWN REGULATION; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; LYMPHOMA; MALE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; TRISOMY;

EID: 18744399909     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6532     Document Type: Article

References (58)

1. World Health Organization. 1999. Global surveillance and control of hepatitis C: report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral Hepat. 6: 35-47.
2. Agnello, V., R. T. Chung, and L. M. Kaplan. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327: 1490-1495.
3. Agnello, V. 1997. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin. Immunopathol 19: 111-129.
4. Fiorilli, M., C. Mecucci, P. Farci, and M. Casato. 2003. HCV-associated lymphomas. Rev. Clin. Exp. Hematol. 7: 406-423.
5. Lunel, F., L. Musset, P. Cacoub, L. Frangeul, P. Cresta, M. Perrin, P. Grippon, C. Hoang, D. Valla, J. C. Piette, et al. 1994. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106: 1291-1300.
6. Mele, A., A. Pulsoni, E. Bianco, P. Musto, A. Szklo, M. G. Sanpaolo, E. Iannitto, A. De Renzo, B. Martino, V. Liso, et al. 2003. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 102: 996-999.
7. Mazzaro, C., F. Franzin, P. Tulissi, E. Pussini, M. Crovatto, G. S. Carniello, D. G. Efremov, O. Burtone, G. Santini, and G. Pozzato. 1996. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy. Cancer 77: 2604-2613.
8. Casato, M., V. Agnello, L. P. Pucillo, G. B. Knight, M. Leoni, S. Del Vecchio, C. Mazzilli, G. Antonelli, and L. Bonomo. 1997. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90: 3865-3873.
9. Gorevic, P. D., and B. Frangione, 1991. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin. Hematol. 28: 79-94.
10. Knight, G. B., V. Agnello, V. Bonagura, J. L. Barnes, D. J. Panka, and Q. X. Zhang. 1993. Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds. J. Exp. Med. 178: 1903-1911.
11. De Re, V., S. De Vita, A. Marzotto, A. Gloghini, B. Pivetta, D. Gasparotto, R. Cannizzaro, A. Carbone, and M. Boiocchi. 2000. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryogtobulinemic patient are sequential phases of an antigen-driven pathological process. Int. J. Cancer 87: 211-216.
12. De Re, V., S. De Vita, A. Marzotto, M. Rupolo, A. Gloghini, B. Pivetta, D. Gasparotto, A. Carbone, and M. Boiocchi. 2000. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96: 3578-3584.
13. L kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 91: 2433-2442.
14. H1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 97: 1023-1026.
15. Hardy, R. R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19: 595-621.
16. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
17. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
18. Tighe, H., P. Heaphy, S. Baird, W. O. Weigle, and D. A. Carson. 1995. Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice. J. Exp. Med. 181: 599-606.
19. Julien, S., P. Soulas, J. C. Garaud, T. Martin, and J. L. Pasquali. 2002. B cell positive selection by soluble self-antigen. J. Immunol. 169: 4198-4204.
20. Hayakawa, K., M. Asano, S. A. Shinton, M. Gui, D. Allman, C. L. Stewart, J. Silver, and R. R. Hardy. 1999. Positive selection of natural autoreactive B cells. Science 285: 113-116.
21. Franco, V., A. M. Florena, and E. Iannitto. 2003. Splenic marginal zone lymphoma. Blood 101: 2464-2472.
22. Casato, M., C. Mecucci, V. Agnello, M. Fiorilli, G. B. Knight, C. Matteucci, L. Gao, and J. Kay. 2002. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 99: 2259-2261.
23. H1-specific variable region determinants recognized by anti-idiotypic monoclonal antibodies G6 and G8. Scand. J. Immunol. 50: 14-20.
24. Fong, S., P. P. Chen, T. A. Gilbertson, J. R. Weber, R. I. Fox, and D. A. Carson. 1986. Expression of three cross-reactive idiotypes on rheumatoid factor autoantibodies from patients with autoimmune diseases and seropositive adults. J. Immunol. 137: 122-128.
25. Carbonari, M., T. Tedesco, and M. Fiorilli. 2003. Human peripheral B cells: a different cytometric point of view. Cytometry 53A: 97-102.
26. Giovannetti, A., F. Mazzetta, E. Caprini, A. Aiuti, M. Marziali, M. Pierdominici, A. Cossarizza, L. Chessa, E. Scala, I. Quinti, et al. 2002. Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia. Blood 100: 4082-4089.
27. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 4673-4680.
28. Lefranc, M. P. 2003. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 31: 307-310.
29. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
30. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188: 1679-1689.
31. Tangye, S. G., Y. J. Liu, G. Aversa, J. H. Phillips, and J. E. de Vries. 1998. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188: 1691-1703.
32. Wotherspoon, A. C., T. M. Finn, and P. G. Isaacson. 1995. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 85: 2000-2004.
33. De Vita, S., V. De Re, D. Gasparotto, M. Ballare, B. Pivetta, G. Ferraccioli, S. Pileri, M. Boiocchi, and A. Monteverde. 2000. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: Clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma. Arthritis Rheum. 43: 94-102.
34. H region gene. J. Immunol. 154: 413-421.
35. De Re, V., S. De Vita, D. Gasparotto, A. Marzotto, A. Carbone, G. Ferraccioli, and M. Boiocchi. 2002. Salivary gland B cell lymphoproliferative disorders in Sjogren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. Eur. J. Immunol. 32: 903-910.
36. Klein, U., R. Kuppers, and K. Rajewsky. 1997. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 89: 1288-1298.
37. Zabel, M. D., and J. H. Weis. 2001. Cell-specific regulation of the CD21 gene. Int. Immunopharmacol. 1: 483-493.
38. Krop, I., A. R. de Fougerolles, R. R. Hardy, M. Allison, M. S. Schlissel, and D. T. Fearon. 1996. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26: 238-242.
39. Bohnhorst, J. Ø., M. B. Bjørgan, J. E. Thoen, J. B. Natvig, and K. M. Thompson. 2001. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjøgren's syndrome. J. Immunol. 167: 3610-3618.
40. Mizuno, T., X. Zhong, and T. L. Rothstein. 2003. Fas-induced apoptosis in B cells. Apoptosis 8: 451-460.
41. Ubara, Y., S. Hara, H. Katori, T. Tagami, A. Kitamura, M. Yokota, Y. Matsushita, F. Takemoto, A. Yamada, K. Nagahama, et al. 2000. Splenectomy may improve the glomerulopathy of type II mixed cryoglobulinemia. Am. J. Kidney Dis. 35: 1186-1192.
42. Kruetzmann, S., M. M. Rosado, H. Weber, U. Germing, O. Tournilhac, H. H. Peter, R. Berner, A. Peters, T. Boehm, A. Plebani, et al. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumonias infections are generated in the spleen. J. Exp. Med. 197: 939-945.
43. Pileri, P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science 282: 938-941.
44. Zibert, A., W. Kraas, R. S. Ross, H. Meisel, S. Lechner, G. Jung, and M. Roggendorf. 1999. Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection. J. Hepatol. 30: 177-184.
45. Stall, A. M., M. C. Farinas, D. M. Tarlinton, P. A. Lalor, L. A. Herzenberg, and S. Strober. 1988. Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New-Zealand Black-related) animals. Proc. Natl. Acad. Sci. USA 85: 7312-7316.
46. LeMaoult, J., J. S. Manavalan, R. Dyall, P. Szabo, J. Nikolic-Zugic, and M. E. Weksler. 1999. Cellular basis of B cell clonal populations in old mice. J. Immunol. 162: 6384-6391.
47. Morse, H. C., 3rd, J. F. Kearney, P. G. Isaacson, M. Carroll, T. N. Fredrickson, and E. S. Jaffe. 2001. Cells of the marginal zone-origins, function and neoplasia. Leuk. Res. 25: 169-178.
48. Giannelli, F., S. Moscarella, C. Giannini, P. Caini, M. Monti, L. Gragnani, R. G. Romanelli, V. Solazzo, G. Laffi, G. La Villa, et al. 2003. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood. 102: 1196-1201.
49. Zuckerman, E., T. Zuckerman, D. Sahar, S. Streichman, D. Attias, E. Sabo, D. Yeshurun, and J. M. Rowe. 2001. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 97: 1555-1559.
50. Hermine, O., F. Lefrere, J. P. Bronowicki, X. Mariette, K. Jondeau, V. Eclache-Saudreau, B. Delmas, F. Valensi, P. Cacoub, C. Brechet, et al. 2002. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med. 347: 89-94.
51. Freitas, A. A., and B. Rocha. 2000. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18: 83-111.
52. Agenes, F., and A. A. Freitas. 1999. Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J. Exp. Med. 189: 319-330.
53. Pietrogrande, M., M. Corona, S. Milani, A. Rosti, M. Ramella, and G. Tordato. 1995. Relationship between rheumatoid factor and the immune response against hepatitis C virus in essential mixed cryoglobulinemia. Clin. Exp. Rheumatol. 13(Suppl. 13): S109-S113.
54. + B cells is associated with mild disease in chronic hepatitis C virus infection. J. Hepatol. 32: 121-125.
55. Zuckerman, E., G. Slobodin, A. Kessel, E. Sabo, D. Yeshurun, K. Halas, and E. Toubi. 2002. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin. Exp. Immunol. 128: 353-358.
56. Zuckerman, E., A. Kessel, G. Slobodin, E. Sabo, D. Yeshurun, and E. Toubi. 2003. Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection. J. Virol. 77: 10432-10436.
57. Ni, J., E. Hembrador, A. M. Di Bisceglie, I. M. Jacobson, A. H. Talal, D. Butera, C. M. Rice, T. J. Chambers, and L. B. Dustin. 2003. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients. J. Immunol. 170: 3429-3439.
58. Du, M. Q., and P. G. Isaccson. 2002. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 3: 97-104.